ascendis pharma glp-1 receptor agonist weight management diabetes treatments Schematic illustration of monoagonists, dual agonists and triple Top GLP-1 Agonists Balance Weight
Description
Lee, Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 Diabetes: a systematic review and meta-analysis
quiz e314-365
These medicines require a valid prescription and medical supervision
As more GLP-1 prescriptions are written to manage not just diabetes and cardiovascular disease but also obesity, a key question emerges: What is the role of patient engagement and chronic disease management when prescribing these drugs
Not for human or veterinary use
Individual experimentation, tracked systematically, will reveal your optimal timing
